New Vitalis Pharmacy is voluntarily recalling 102 vials of compounded Testosterone Cypionate-Testosterone Propionate (180-20 mg/mL) injectable medication due to a lack of assurance of sterility. The recall includes both 1 mL and 5 mL multi-dose vials in cottonseed oil intended for intramuscular use. Because these products are injected, any compromise in sterility could lead to serious infections.
Injectable medications that are not sterile can introduce bacteria or other contaminants directly into the body, potentially causing severe infections. No injuries or adverse reactions have been reported to date for this recall.
You have 2 options:
Recall #: D-0944-2023. For Intramuscular Use Only.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.